1.Wollert K.C., Meyer G.P., Lotz J. et al. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomisedcontrolled clinical trial. Lancet 2004; 364: 141-8.2.Heil M., Ziegelhoeffer T., Mees B., Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ. Res. 2004; 94: 573-4.3.Kocher A.A., Schuster M.D., Szabolcs M.J. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001 ; 7: 430-6.4.Aicher A., Brenner W., Zuhayra M. et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circ. 2003; 107: 2134-9.5.Brenner W., Aicher A., Eckey T. et al. 111 -In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J. Nucl. Med. 2004; 45: 512-8.6.Rookmaaker M.B., Verhaar M.C., Loomans C.J. et al. CD34+ oells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arterioscler. Thromb. Vasc. Biol. 2005;25[9]:1843-50.7.Шумаков В.И., Казаков Э.Н., Онищенко Н.А. и др. Первый опыт клинического применения аутологичных мезенхимальных стволовых клеток костного мозга для восстановления сократительной функции миокарда. Российский Кардиологический Журнал, 2003; 5: 42-50.